Omnicell Revenue 2010-2023 | OMCL
Omnicell revenue from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Omnicell Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,147 |
| 2022 | $1,296 |
| 2021 | $1,132 |
| 2020 | $892 |
| 2019 | $897 |
| 2018 | $787 |
| 2017 | $713 |
| 2016 | $696 |
| 2015 | $485 |
| 2014 | $441 |
| 2013 | $381 |
| 2012 | $314 |
| 2011 | $246 |
| 2010 | $222 |
| 2009 | $213 |
| Omnicell Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $259 |
| 2023-09-30 | $299 |
| 2023-06-30 | $299 |
| 2023-03-31 | $291 |
| 2022-12-31 | $298 |
| 2022-09-30 | $348 |
| 2022-06-30 | $331 |
| 2022-03-31 | $319 |
| 2021-12-31 | $311 |
| 2021-09-30 | $296 |
| 2021-06-30 | $273 |
| 2021-03-31 | $252 |
| 2020-12-31 | $249 |
| 2020-09-30 | $214 |
| 2020-06-30 | $200 |
| 2020-03-31 | $230 |
| 2019-12-31 | $248 |
| 2019-09-30 | $229 |
| 2019-06-30 | $217 |
| 2019-03-31 | $203 |
| 2018-12-31 | $212 |
| 2018-09-30 | $204 |
| 2018-06-30 | $189 |
| 2018-03-31 | $183 |
| 2017-12-31 | $196 |
| 2017-09-30 | $187 |
| 2017-06-30 | $181 |
| 2017-03-31 | $149 |
| 2016-12-31 | $175 |
| 2016-09-30 | $177 |
| 2016-06-30 | $173 |
| 2016-03-31 | $171 |
| 2015-12-31 | $130 |
| 2015-09-30 | $125 |
| 2015-06-30 | $113 |
| 2015-03-31 | $116 |
| 2014-12-31 | $122 |
| 2014-09-30 | $113 |
| 2014-06-30 | $105 |
| 2014-03-31 | $102 |
| 2013-12-31 | $106 |
| 2013-09-30 | $94 |
| 2013-06-30 | $94 |
| 2013-03-31 | $87 |
| 2012-12-31 | $90 |
| 2012-09-30 | $84 |
| 2012-06-30 | $75 |
| 2012-03-31 | $64 |
| 2011-12-31 | $63 |
| 2011-09-30 | $64 |
| 2011-06-30 | $61 |
| 2011-03-31 | $57 |
| 2010-12-31 | $57 |
| 2010-09-30 | $56 |
| 2010-06-30 | $55 |
| 2010-03-31 | $54 |
| 2009-12-31 | $55 |
| 2009-09-30 | $54 |
| 2009-06-30 | $53 |
| 2009-03-31 | $52 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.206B | $1.147B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.875B | 21.62 |
| Inspire Medical Systems (INSP) | United States | $7.378B | 0.00 |
| 10x Genomics (TXG) | United States | $3.475B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.470B | 0.00 |
| Axonics (AXNX) | United States | $3.427B | 0.00 |
| Enovis (ENOV) | United States | $3.084B | 23.43 |
| Azenta (AZTA) | United States | $2.854B | 232.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.772B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.659B | 0.00 |
| Privia Health (PRVA) | United States | $2.118B | 93.95 |
| Schrodinger (SDGR) | United States | $1.811B | 0.00 |
| Phreesia (PHR) | United States | $1.306B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.847B | 0.00 |
| Standard BioTools (LAB) | United States | $0.757B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.497B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.316B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.308B | 0.00 |
| Pulmonx (LUNG) | United States | $0.286B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| Augmedix (AUGX) | United States | $0.155B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.122B | 5.19 |
| Outset Medical (OM) | United States | $0.112B | 0.00 |
| 111 (YI) | China | $0.081B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.076B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| Akili (AKLI) | United States | $0.017B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |